Antiviral Treatments Should Work Well Against Omicron, Experts Say
FRIDAY, Dec. 10, 2021 (HealthDay News) — The Omicron variant could prompt a reshuffling of the way doctors treat COVID infections in the United States, and antiviral pills will likely lead the way in that redoubled effort, Harvard experts say. New antiviral pills developed by Merck and Pfizer are expectedContinue Reading